By activating GLP-1, GIP, and glucagon receptors, it enables researchers to examine how overlapping endocrine systems regulate glucose uptake, nutrient distribution, and cellular energy utilization
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you
Everything in this post is my personal experience, not medical advice
Both drugs use semaglutide, a GLP-1 RA, and are manufactured by Novo Nordisk
However, theyre not appropriate for pregnant or breastfeeding women, women trying to become pregnant, and people with a history of pancreatitis, certain cancers, some gastrointestinal conditions, or certain kidney diseases